State Street Corp Catalent, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Catalent, Inc. stock. As of the latest transaction made, State Street Corp holds 7,451,135 shares of CTLT stock, worth $458 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,451,135

Previous 7,338,040 1.54%

Holding current value

$458 Million

Previous $413 Million 9.38%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $6.35 Million - $6.89 Million	113,095 Added 1.54%	7,451,135 $451 Million
Q2 2024 Aug 14, 2024	SELL	$53.58 - $57.02 $4.46 Million - $4.75 Million	-83,224 Reduced 1.12%	7,338,040 $413 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $1.48 Million - $2.08 Million	-34,794 Reduced 0.47%	7,421,264 $419 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $6.15 Million - $8.9 Million	191,128 Added 2.63%	7,456,058 $335 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $12 Million - $13.6 Million	-270,970 Reduced 3.6%	7,264,930 $331 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $10.7 Million - $22.7 Million	337,297 Added 4.69%	7,535,900 $327 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $7.67 Million - $12.5 Million	-168,718 Reduced 2.29%	7,198,603 $473 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $9.96 Million - $19.5 Million	240,521 Added 3.37%	7,367,321 $331 Million
Q3 2022 Nov 15, 2022	BUY	$72.36 - $113.1 $4.85 Million - $7.58 Million	67,054 Added 0.95%	7,126,800 $516 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $5.81 Million - $7.61 Million	-66,683 Reduced 0.94%	7,059,746 $757 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $24.6 Million - $32.6 Million	261,686 Added 3.81%	7,126,429 $790 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $24 Million - $27.9 Million	200,680 Added 3.01%	6,864,743 $879 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $5.53 Million - $7.22 Million	50,687 Added 0.77%	6,664,063 $887 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $24.1 Million - $27.8 Million	240,541 Added 3.77%	6,613,376 $715 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $9.69 Million - $12 Million	-95,439 Reduced 1.48%	6,372,835 $671 Million
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $5.21 Million - $6.39 Million	-60,688 Reduced 0.93%	6,468,274 $673 Million
Q3 2020 Nov 10, 2020	BUY	$72.74 - $92.5 $106 Million - $135 Million	1,455,983 Added 28.7%	6,528,962 $559 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $62.8 Million - $103 Million	1,307,547 Added 34.73%	5,072,979 $372 Million
Q1 2020 May 11, 2020	BUY	$36.95 - $62.95 $139 Million - $237 Million	3,765,432 New	3,765,432 $196 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.1B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Catalent, Inc. Transaction History